Lim, Soon-Thye <br/><br/>
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma.  [electronic resource] 

 -  Leukemia & lymphoma  Feb 2007 
 - 374-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/10428190601060496  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics<br/>Cisplatin--administration & dosage<br/>Cytarabine--administration & dosage<br/>Female<br/>Humans<br/>Isoquinolines--administration & dosage<br/>Lymphoma, B-Cell--drug therapy<br/>Lymphoma, Follicular--drug therapy<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Methylprednisolone--administration & dosage<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prospective Studies<br/>Remission Induction<br/>Salvage Therapy<br/>Treatment Outcome